Pasquali Sara K, Shera David, Wernovsky Gil, Cohen Meryl S, Tabbutt Sarah, Nicolson Susan, Spray Thomas L, Marino Bradley S
Division of Cardiology in the Departments of Pediatrics, Surgery, and Anesthesia/Critical Care Medicine at The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa 19104, USA.
J Thorac Cardiovasc Surg. 2007 Apr;133(4):893-9. doi: 10.1016/j.jtcvs.2006.12.006.
This study assessed the type, time course, and risk factors for right and left ventricular outflow tract reinterventions after the Ross procedure in a population of infants, children, and young adults.
Patients who underwent the Ross procedure between January 1995 and June 2004 were included (n = 121 consecutive patients). Kaplan-Meier and hazard analyses of right and left ventricular outflow tract reinterventions were performed, and predictors of reintervention were identified through multivariate analysis.
The median age at the Ross procedure was 8.2 years (4 days to 34 years); 20% were aged less than 1 year. Half of the patients had isolated aortic valve disease; the other half had complex left-sided heart disease. Early mortality (<30 days) was 2.5% (n = 3). There were 2 late deaths (1.7%). Follow-up (median 6.5 years [2.5 months to 10.4 years]) was available for 96% of survivors (n = 111). Right ventricular outflow tract reintervention (n = 22 in 15 patients) was performed 2.0 years (2.0 weeks to 9.8 years) after the Ross procedure because of stenosis in 19 of 22 cases. Freedom from right ventricular outflow tract reintervention at 8 years was 81%. Smaller homograft size was the strongest predictor (P < .001) of right ventricular outflow tract reintervention. Left ventricular outflow tract reintervention (n = 15 in 15 patients) was performed 2.8 years (1.0 months to 11.6 years) after the Ross procedure because of severe neoaortic insufficiency in 10 of 15 patients. Freedom from left ventricular outflow tract reintervention at 8 years was 83%. Native pulmonary valve abnormalities (P < .01), original diagnosis of aortic insufficiency (P < .01), prior aortic valve replacement (P = .01), and prior ventricular septal defect repair (P = .04) predicted left ventricular outflow tract reintervention.
At midterm follow-up after the Ross procedure, interim mortality is rare. Neoaortic insufficiency and right ventricle to pulmonary artery conduit obstruction are common postoperative sequelae, requiring reintervention in one quarter of patients.
本研究评估了婴儿、儿童及青年人群在罗斯手术(Ross procedure)后右心室和左心室流出道再次干预的类型、时间进程及危险因素。
纳入1995年1月至2004年6月期间接受罗斯手术的患者(共121例连续患者)。对右心室和左心室流出道再次干预进行了Kaplan-Meier分析和风险分析,并通过多变量分析确定再次干预的预测因素。
罗斯手术时的中位年龄为8.2岁(4天至34岁);20%的患者年龄小于1岁。一半患者患有孤立性主动脉瓣疾病;另一半患有复杂性左侧心脏病。早期死亡率(<30天)为2.5%(n = 3)。有2例晚期死亡(1.7%)。96%的幸存者(n = 111)获得随访(中位随访时间6.5年[2.5个月至10.4年])。15例患者中有22次右心室流出道再次干预,在罗斯手术后2.0年(2.0周至9.8年)进行,22例中有19例是由于狭窄。8年时无右心室流出道再次干预的概率为81%。较小的同种异体移植物尺寸是右心室流出道再次干预的最强预测因素(P < .001)。15例患者中有15次左心室流出道再次干预,在罗斯手术后2.8年(1.0个月至11.6年)进行,15例中有10例是由于严重的新主动脉瓣关闭不全。8年时无左心室流出道再次干预的概率为83%。原生肺动脉瓣异常(P < .01)、主动脉瓣关闭不全的初始诊断(P < .01)、既往主动脉瓣置换术(P = .01)和既往室间隔缺损修复术(P = .04)可预测左心室流出道再次干预。
在罗斯手术后的中期随访中,中期死亡率罕见。新主动脉瓣关闭不全和右心室至肺动脉导管梗阻是常见的术后后遗症,四分之一的患者需要再次干预。